EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, FULC: Fulcrum Therapeutics Inc

23 Oct 26 15:59
LAST:

3.685

CHANGE:
 0.00		OPEN:
3.740		HIGH:
3.740		ASK:
0.000		VOLUME:
829.1K
CHG(%):
0.00		PREV:
3.680		LOW:
3.640		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Oct 263.6803.6903.6403.6801.07M
22 Oct 263.7103.7353.6603.6802.31M
21 Oct 263.7203.7453.7003.700923.7K
20 Oct 263.7103.7503.6953.720757.1K
19 Oct 263.6703.7203.6603.7001.19M
16 Oct 263.6803.6853.6403.6501.39M
15 Oct 263.7103.7253.6603.6701.23M
14 Oct 263.6703.7153.6503.6701.66M
13 Oct 263.7503.7503.6753.6801.46M
12 Oct 263.7703.7703.7303.7501.61M

PROFILE

Name:Fulcrum Therapeutics Inc
About:Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers drug targets for potential treatment inherited aplastic anemias, such as of diamond-blackfan anemia, shwachman-diamond syndrome, and fanconi anemia, as well as novel fetal hemoglobin inducers, fibrotic disorders, and cardiomyopathies which is in preclinical trial. It has collaboration and license agreement with MyoKardia, Inc. to identify biological targets that are capable of modulating genes of interest with relevance to cardiomyopathies; and licensce agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize; and Sanofi for the development and commercialization of losmapimod, an oral small molecule being investigated for the treatment of facioscapulohumeral muscular dystrophy. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:26 Landsdowne Street, Cambridge, MA, United States, 02139
Website:https://www.fulcrumtx.com
CUSIP:359616109
CIK:0001680581
ISIN:US3596161097
FIGI:BBG00DDY1RK9

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-56.38 
Forward P/E:-6.74 
PEG Ratio:0.43 
Price to Sales:6.10 
Price to Book:0.91 
Operating Margin:-0.25 
Return on Assets:-0.21 
Return on Equity:-0.31 
EPS Ratio:-1.21 
Revenue:80.0M 
Shares:76.3M 
Market Cap:281.16M 

TECHNICAL INDICATORS

MA5:3.700.3%
MA10:3.690.1%
MA20:3.700.4%
MA50:3.772.4%
MA100:3.710.7%
MA200:6.0263.4%
STO9:30.00
STO14:22.22
RSI14:45.95
WPR14:-75.00
MTM14:-0.01
ROC14:0.00 
ATR:0.06 
Week High:3.751.8%
Week Low:3.641.2%
Month High:3.864.7%
Month Low:3.6463.4%
Year High:15.74327.1%
Year Low:2.8330.2%
Volatility:3.74